Autoimmunovascular regulation: morphine and ancondamide and ancondamide stimulated nitric oxide release
- 15 March 1998
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 83 (1-2), 70-76
- https://doi.org/10.1016/s0165-5728(97)00223-3
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Opioid and Opiate Immunoregulatory ProcessesCritical Reviews in Immunology, 1996
- Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthaseGeneral Pharmacology: The Vascular System, 1995
- Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptorFEBS Letters, 1995
- Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1FEBS Letters, 1995
- Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinolLife Sciences, 1994
- Δ9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell linesLife Sciences, 1994
- Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cordLife Sciences, 1993
- Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophagesInternational Journal of Immunopharmacology, 1992
- Marijuana and immunity: Tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1International Journal of Immunopharmacology, 1992
- Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infectionInternational Journal of Immunopharmacology, 1991